Abstract

BackgroundBiologic agents provide clinical benefits in patients with Rheumatoid Arthritis (RA) but they are associated with an increased risk of tuberculosis (TB) infection.ObjectivesWe investigated the accordance between the tuberculin skin...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Discordance of tuberculin skin test and interferon gamma release assay in recently exposed household contacts of pulmonary TB cases in Brazil.
Moíses Palaci ... Reynaldo Dietze
PloS one | VOL. 9
Moíses Palaci, et. al.Moíses Palaci ... Reynaldo Dietze
12 May 2014
Diagnosing Latent Tuberculosis Infection in the HIV Era
Philippe Lagrange
The Open Respiratory Medicine Journal | VOL. 2
Philippe LagrangePhilippe Lagrange
23 May 2008
FRI0268 Multifunctional Flow Cytometry Analysis of CD4+ T Cells as an Immune Biomarker for Latent Tuberculosis Status in Patients Treated with TNF Antagonists
...
Annals of the Rheumatic Diseases | VOL. 73
, et. al. ...
01 Jun 2014
Mycobacterium tuberculosis Infections in Solid Organ Transplantation
M.I Morris ... A.K Subramanian
American Journal of Transplantation | VOL. 13
M.I Morris, et. al.M.I Morris ... A.K Subramanian
01 Mar 2013
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers